Straumann USA is on The BRIDGE!
The BRIDGE is an online network from LMT dedicated exclusively for members of the Dental Laboratory community. Join free to connect with Straumann USA.
The BRIDGE is an online network from LMT dedicated exclusively for members of the Dental Laboratory community. Join free to connect with Straumann USA.
Straumann CARES Digital Solutions: Digital Dentistry for the Lab
The Straumann CARES (Computer Aided Restorative Solutions) Digital Solutions portfolio includes state-of-the-art guided surgery, intra-oral impressions and scanning, and CADCAM solutions. CARES focuses on the end result – a beautiful, natural restorative solution for the patient. A wide variety of materials and applications offer technicians treatment flexibility to design virtually any type of restoration. Partnerships with Dental Wings and 3M ESPE will offer software standardization designed to reduce the laboratory’s investment in capital equipment.
As digital dentistry continues to grow and replace labor intensive analogue processes, and shorten treatment times, Straumann is committed to offering solutions that meet the changing needs of the dental laboratory.
Visit us online http://bit.ly/yN6haX and learn how our digital solutions portfolio can be customized to meet your laboratory’s needs.
With an eye on increasing efficiency, Straumann launched the latest version of its CAD/CAM software, Straumann CARES Visual 8.0 during Lab Day Chicago. The enhanced software delivers optimized digital...See more workflows, increased design flexibilities, improved ease of use, and an extended prosthetic product portfolio for implant- and tooth-borne restorations. "The new software—which comes just 12 months after the release of version 7—along with the implementation of Straumann's new laboratory division last Spring, reaffirms Straumann's strong commitment to the laboratory industry. Despite recent concerns about the direction Straumann is taking in regards to digital workflows, I believe the investments in our new division and our increased stake in Dental Wings further confirms that commitment," said Steve Sheehan, Vice President, Lab Division, North America. CARES 8.0 completes the integration of the CARES® Visual Software onto the Dental Wings Open Software platform and features various time-saving functionalities like CARES X-Stream™, a one-step, single-tooth implant-based prosthetic restoration process. It allows you to simultaneously design a customized abutment and full-contour crown or coping and requires only one scan and design step and one shipment for all required components. The advantages are reduced turnaround time and shipment costs as well as excellent fit and consistent and reproducible quality. More introductions from Straumann in Chicago include: The CARES Variobase™ Abutment, a hybrid abutment with a titanium bonding base and a zirconium dioxide coping. This offers laboratories the combined benefit of a metal-to-metal implant abutment with an original Straumann connection and a variety of shades. New full contour zerion® HT, a translucent zirconium dioxide ceramic for full contour restorations. The material is available in four esthetic shades and requires minimal processing. New software functionalities for increased efficiency: simultaneous scan and design, patented* morphing algorithms, mirroring functionality and more. Four new bar designs for Straumann's tissue-level bar platform. Laboratories now have more bar choices on the tissue- level platform for restorations up to 16 units. For more information, call Straumann at 800-448-8168 or visit www.straumann.us/CARES8. *Patent pending in the U.S.
At LAB DAY, Nobel Biocare presented its latest innovations in dental implant-based CAD/CAM solutions, including: NobelProcera® Abutments, now available on Biomet 3i, Camlog and Zimmer implant platforms...See more (in addition to Straumann, Astra Tech and Thommen). NobelProcera users can expand their business with the new in-lab scanning of NobelProcera Implant Bar Overdenture for Straumann implant platforms. These bars have been tested with a new 3D fit assessment to verify the precision of fit, reduce mechanical complications and ensure longevity. Available later this year, the new NobelProcera 2G Scanner has a similar look and feel to the original with new elements including advanced automation features designed to increase productivity. Existing users of the NobelProcera Scanner will be able to upgrade their current scanner to the new 2G version for a modest fee. Also later this year, Nobel Biocare is forming a partnership with 3Shape that will enable 3Shape users to access NobelProcera Abutments in zirconia and titanium. After integrating with NobelProcera, 3Shape users simply maintain their current workflow of scanning and designing using the 3Shape Dental System; interested 3Shape users should contact Nobel Biocare to obtain the required interface file. Availability may depend on which 3Shape partner has provided the system. For more information, visit www.nobelbiocare.com.
From new ways to digitize workflows to product launches and enhanced equipment and software, the DLOACâs CAD/CAM Expo and Symposium was the place to be to learn about the latest in digital technology.
Both zirconia and metal lack fluorescent qualities, which we should attempt to re-create when restoring the oral cavity with fixed prosthetic restorations. When applying porcelain to a zirconia or metal...See more coping or framework, it is helpful to use a porcelain material that has fluorescent properties to add vitality to the substrate. In this article, we use several different shades of zirconia (zerion®) frameworks from Straumann with Creation® ZI Porcelain System* to demonstrate how to use a fluorescent dentin material to match shades. Today, most dental porcelain companies provide materials with fluorescent qualities and by using them you will create a restoration that is lifelike which the dentist and patient demand. *© Creation Willi Geller International AG Peter Kouvaris is a world renowned master ceramist with over 30 years' experience as well as a member of the prestigious Oral Design International Foundation. In addition to being mentored by the revered Willi Geller, he has studied under other highly regarded technologists such as Walter Gebhard and Claude Sieber. Peter has received academic achievement awards for his knowledge on implant dentistry. For the last 20 years he has lectured nationally and internationally on shade taking, color, case sequencing, and material sciences along with ceramic and metal design. He also lectures on predictable aesthetics utilizing the Dawson concept of occlusion combined with unsurpassed ceramics. Peter is one of the instructors and technicians of the International Aesthetic Advantage program under the guidance of Dr. Larry Rosenthal and is a faculty member of New York University's Continuing Education technical programs.
As part of our continuous effort to provide dental laboratories with best-in-class products, we are happy to announce two enhancements to our CARES portfolio that provide laboratories more flexibility
New lighter and more translucent zerion shades, along with larger blank sizes for ZrO2 customized abutments, are now available for CARES laboratories.
On behalf of every attendee who participates in a Straumann product demo at LAB DAY Chicago, the company will make a $10 donation to the Sandy Hook School Support Fund. The fund supports the families and...See more community of the 20 first graders and six adults who were killed by a gunman at the Newtown, CT elementary school in December. "Straumann regularly drives charitable donations at its larger trade shows and, at LAB DAY, we wanted to honor the Sandy Hook tragedy and LMT's hometown," says Valerie Andren, Manager, Marketing Communications. This year's demos focus on the company's new CARES System 8.0 software. To participate, visit Straumann in the Sheraton 1 Ballroom, go to http://straumann.us/labday or call 978-747-2535 for more information.
Straumann reported stable net revenues of CHF 519 million (-1% in local currencies) in the first nine-months of 2012. North America was the key driver throughout accompanied by strong growth in China and...See more Latin America. However, these solid performances were not enough to compensate for sluggish sales elsewhere - particularly in Europe, where the tooth replacement market has suffered from further deterioration in the economic environment. In the third quarter, sales in local currencies were generally slower with the exception of the 'Rest of the World' region. As a result, Group net revenue for the quarter was 2% off the prior year level. In Swiss francs, however, the top line grew 4%, lifted by positive currency effects. In addition to the business results, the Group announced further initiatives in its strategy for digital dentistry. Straumann plans to strengthen its collaboration with Dental Wings by transferring its software development teams and increasing its stake in Dental Wings by the end of 2012. The Group also announced resizing targets as it adapts to the current economic environment. These will lead to a reduction of approximately 150 positions worldwide by early 2013, of which about 90 will be redundancies. Straumann's President & CEO, Beat Spalinger commented: "With our margins reaching unacceptable levels in the first half of the year, we scrutinized our cost structure and determined substantial, balanced resizing measures that will not compromise our growth prospects. The initiatives we are announcing today will help restore decent margins, even if the market remains sluggish. Unfortunately, we won't be able to achieve the necessary reductions without redundancies, which the Group pledges to carry out with full regard to its social responsibilities and obligations. We are also announcing important initiatives that usher in the next phase of our digital strategy. In view of the integration of our CARES software into the DWOS open platform, we have agreed with Dental Wings to combine our software development teams to support and drive leading-edge software solutions. To underpin this strengthened partnership, Straumann will increase its stake in Dental Wings to around 45%." BUSINESS AND REGIONAL PERFORMANCES Straumann's core implant business posted the same level of sales over the nine-month period, year on year. Difficult market conditions in Europe (owing to the poor economy) and in Japan (due to negative media publicity) prevented a return to growth. The Group's CADCAM/digital business was expectedly slower than in the comparative period of 2011, which benefited from new scanner roll-outs. Straumann's smallest unit, Regeneratives, again posted double-digit growth, driven by bone augmentation products and the launch of Emdogain 015. Patience needed for turnaround in Europe The European tooth-replacement market relies on patients' ability to finance non-reimbursed procedures and thus continues to suffer from the weak economic environment. With austerity measures deepening the dents in consumer confidence, the regional market dipped further, pushing Straumann's revenues down 5% (l.c.) both in Q3 and over the nine-month period. Net revenue in the respective periods reached CHF 82 million and CHF 284 million, corresponding to 55% of the Group. The weakness of the Euro against the Swiss franc resulted in a negative currency impact of almost 2 percentage points over nine months. However, thanks to the Swiss National Bank's implementation of a minimum exchange rate for the Euro since September 2011, the currency effect on Straumann's European revenue turned positive in Q3 2012, for the first time in many quarters. The region was weighed down in Q3 by Iberia, the Netherlands and Sweden. Germany was also unable to repeat the prior year's performance in contrast to France and the UK, which both continued to perform well. Solid growth in North America Straumann's second largest region, North America, achieved strong growth of 9% (l.c.) over the first nine months. Sales continued to grow in the third quarter, albeit at a slower rate. The reason why momentum has eased over the past two quarters of this year is twofold: first the market was softer in general, and second, the Group benefitted from the introduction of new scanners in 2011. This means that the solid third quarter growth (+5% l.c.) this year was driven by strong performances in Implants and Regeneratives. The appreciation of the US dollar against the Swiss franc lifted nine-month sales growth by 6 percentage points to 15% in Swiss francs. As a result, North America achieved revenue of CHF 131 million (CHF 42 million in Q3) corresponding to a quarter of Group net revenue. Revenues maintained in Asia/Pacific The Asia/Pacific region remained stable over nine months and contracted 2% (l.c.) in Q3, with respective revenues reaching CHF 80 million and CHF 26 million, corresponding to approximately 15% of Group sales. The region's largest market, Japan, was constrained by the contracting economy and was tainted by negative media reports. As noted previously, dynamic growth in China was the region's key performance driver in Q3, complemented by a pick-up in Australia. Strong growth in parts of the Rest of the World In the 'Rest of the World', net revenue in the first nine months declined 1% in l.c. or 5% in Swiss francs. Strong expansion in Latin America was not able to offset the uncertainty in the Middle East. With net revenue reaching CHF 24 million over the nine-month period and CHF 7 million in Q3, the region contributed 5% to the Group total. STRATEGIC AND OPERATIONAL PROGRESS Straumann's digital dentistry strategy enters next phase Insights from Straumann's Vision 2020 project indicate that implant surgery and prosthetic planning will converge into one software solution in the future. For the past two years, Straumann has been working together with Dental Wings on the integration of its CARES® prosthetic planning software onto the open Dental Wings platform (DWOS). This integration will be concluded with the release of the new CARES 8.0 software early in 2013. In order to drive development to the next level, the two companies have announced their plans to combine their resources further. Straumann's guided surgery business, including its development and operations units in Chemnitz, Germany, is to be transferred to Dental Wings effective as of 1 January 2013. So too will Straumann's prosthetic software development team based in Berlin. Over time, Straumann's guided surgery software and treatment planning shall be integrated in Dental Wings' software core. The transfer will considerably strengthen Dental Wings as a software power-house in digital dentistry and will add critical mass to the development of treatment planning solutions. While Dental Wings will provide the core technology, Straumann will concentrate on the digital workflow and solutions that add value for customers - both in terms of products and services. The Group will continue to promote guided surgery software and to provide first-level customer support. It will also continue to develop, sell and support proprietary implant-borne and tooth-borne restoration work-flows. Increased participation in Dental Wings As a further confirmation of its commitment to digital dentistry and the DWOS open standard software platform, Straumann announced its intention to increase its participation in Dental Wings from 30% to around 45% by year-end for an undisclosed sum. The two companies will continue to collaborate with 3M ESPE to establish DWOS as the standard software of choice in dentistry. Straumann's increased stake in Dental Wings is not intended to make the partnership exclusive. On the contrary, the partners welcome additional participants to join the open software standardization initiative. Distribution of intraoral scanning hardware discontinued As announced on 18 October, Straumann has decided to step back from distributing the iTero intra-oral scanner globally. While the company firmly believes iTero is one of the best scanners available and that intra-oral scanning will have an increasingly central position in daily dental practice, it does not consider the business case for operating as a hardware distributor to be viable in the present economic environment. Having built a digital prosthetics platform that is open to multiple scanners, Straumann's ambition is to attract business from users of other scanners, in addition to iTero. Focusing on essentials and resizing Based on insights from Straumann's Vision 2020, and to adapt to market developments, the Group has reviewed its entire cost structure to question what is essential. Apart from discontinuing the distribution of iTero scanners, the company has identified various measures to optimize costs, including streamlining and focusing its development portfolio, adapting its sales organization in markets that are heavily affected by the economic slowdown, and by optimizing its service functions. The primary goal is to restore acceptable margin levels - even if the markets remain sluggish - without compromising the Group's ability to capture market potential, to achieve sustainable growth, and to attain its Vision 2020 targets. The combination of all the above initiatives (including the discontinuation of intra-oral scanner distribution and the transfer of personnel to Dental Wings) will lead to a reduction of approximately 150 positions worldwide by early 2013, corresponding to approximately 6% of the Group's global workforce, which stood at 2 575 on 30 September. This will be achieved as far as possible through transfers or natural fluctuation, although a substantial portion will be through redundancies. Straumann is fully aware of its social responsibilities in this respect and will offer affected staff the appropriate redundancy package and outplacement support. These initiatives are expected to result in an annualized EBIT improvement of CHF 35-40 million by 2014 and an exceptional charge of CHF 15-20 million in 2012. OUTLOOK (barring unforeseen circumstances) The Group confirmed its outlook for the full-year 2012. It continues to expect challenging developments - especially in parts of Europe and Asia, while the outlook for North America and emerging markets is more optimistic. Current macroeconomic indicators suggest that the aggregated global market for tooth replacement may remain soft and thus flat, at best, over the full year. For 2012, the Group is confident that it can achieve full-year revenues in line with the 2011 level - excluding currency effects, which Straumann expects to be positive for 2012 as a whole. As the cost savings will only have minor impact in 2012, Straumann still expects the 2012 full-year EBIT margin to be similar to the reported first-half level, excluding exceptional costs in the second half related to the initiatives announced today.